DIGOXIN tablet labels and packages

Revision as of 14:29, 28 February 2014 by Abdurahman Khalil (talk | contribs) (Created page with "__NOTOC__ {{Digoxin}} {{CMG}}; {{AE}}:{{AK}} '''''For patient information about Digoxin, click here.''''' '''PRINCIPAL DISPLAY PANEL NDC 0...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Digoxin
DIGOXIN injection® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
DIGOXIN tablet® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: :Abdurahman Khalil, M.D. [2]

For patient information about Digoxin, click here.

PRINCIPAL DISPLAY PANEL

NDC 0143-1240-01 Digoxin Tablets, USP 125 mcg (0.125 mg) Rx Only 100 Tablets

PRINCIPAL DISPLAY PANEL

NDC 0143-1241-01 Digoxin Tablets, USP 250 mcg (0.25 mg) Rx Only 100 Tablets


References

Retrieved from "https://www.wikidoc.org/index.php?title=DIGOXIN_tablet_labels_and_packages&oldid=949002"